Recombinant Quadrivalent Flu Vaccine More Effective in Older Adults

A clinical trial comparing the protective efficacy in older adults of a quadrivalent recombinant influenza vaccine with a standard-dose, egg-grown quadrivalent inactivated influenza vaccine during the A/H3N2-predominant 2014-2015 influenza season showed RIV4 provided better protection against confirmed influenza-like illness among older adults.

CDC Study Shows Flu Vaccine Reduces Risk of Death in Children

A new study conducted by the Centers for Disease Control and Prevention shows that during the years 2010 through 2014, the influenza vaccine reduced the risk of flu-associated death by half among children with underlying high-risk medical conditions and by nearly two-thirds among healthy children.